Prescription Drug Advertising and Promotional Labeling

Part of CDER's mission is to assure that prescription drug information provided by drug firms is truthful, balanced, and accurately communicated. This is accomplished through a comprehensive surveillance, enforcement, and education program, and by fostering better communications of labeling and promotional information to both health professionals and consumers. This work is accomplished primarily through CDER's Division of Drug Marketing, Advertising and Communications (DDMAC).

	Promotional Materials Review Process- An interactive chart that provides an overview of CDER's process for reviewing and monitoring prescription drug advertising and promotional labeling provided by drug firms.
	DDMAC Home Page- Click here for further information on CDER's Division of Drug Marketing, Advertising and Communications.

Also...

	Advertising/Labeling Definitions		Patient Information/Education
	Labeling Research		Policy and Guidance Development